2Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry [J]. Circ Res, 2003, 92 (8) : 827 - 839.
3Marti HP. Role of matrix metalloproteinases in the progression of renal lesions [J]. Presse Med, 2000, 29( 14): 811-817.
4Vu TH, Werb Z. Matrix metalloproteinases: effectors of development and normal physiology [J]. Genes Dev, 2000, 14(17) : 2123 -2133.
5Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior [J]. Annu Rev Cell Dev Biol, 2001, 17( 1 ) : 463 -516.
6Kuzuya M, Lguchi A. Role of matrix metalloproteinases in vascular remodeling [ J ]. J Atheroscler Thromb, 2003, 10 (5) : 275 - 282.
7Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP-9 [J ]. J Clin Invest, 2004, 113(10) : 1447 -1455.
8Suehiro E, Fujisawa H, Akimura T, et al. Increased matrix metalloproteinase-9 in blood in association with activation of interleukin- 6 after traumatic brain injury : influence of hypothermic therapy [ J ]. J Neurotrauma, 2004, 21 ( 12 ) : 1706 - 1711.
9Wang X, Mori T, Jung JC, et al. Secretion of matrix metalloproteinase- 2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase [ J ]. J Neurotrauma, 2002, 19 (5) : 615 - 625.
10Szklarezyk A, Lapinska 1, Rylski M, et al. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus [J]. J Neurosci, 2002, 22(3) : 920-930.
二级参考文献11
1Lukes A,Mun-Bryce S,Lukes M,et al. Extracellular matrix degradation by metalloproteinases and central nervous system desease[J]. Mol Neurobiol,1999,19(3): 267-284.
2Clark AW,Krekoski CA,Bou SS,et al. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia[J]. Neurosci Lett,1997,238(1-2): 53-56.
3Asahi M,Asahi K,Jung JC,et al. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94[J]. J Cereb Blood Flow Metab,2000,20(12): 1681-1689.
4Gasche Y,Fujimura M,Morita-Fujimura Y,et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood brain barrier dysfunction[J]. J Cereb Blood Flow Metab,1999,19(9): 1020-1028.
5Heo JH,Lucero J,Abumiya T,et al. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia[J]. J Cereb Blood Flow Metab,1999,19(6): 624-633.
6Hattori K,Hirano T,Ushiyama C,et al. A metalloproteinase inhibitor prevents lethal acute graft-versus-host disease in mice[J]. Blood,1997,90(2): 542-548.
7Nagase H,Woessner JF Jr. Matrix metalloproteinases[J]. J Biol Chem,1999,274(31): 21491-21494.
8Chan PH. Role of oxidants in ischemic brain damage[J]. Stroke,1996,27(6): 1124-1129.
9Morita-Fujimura Y,Fujimura M,Gasche Y,et al. Overexpression of copper and zinc superoxide dismutase in transgenic mice prevents the induction and activation of matrix metalloproteinases after cold injury-induced brain trauma[J]. J Cereb Blood Flow Metab,2000,20(1): 130-138.
